|
Mean values (CI) for HAD scores before treatment (baseline) and follow-up and p-values and effect sizes for changes at follow-up compared to baseline |
||||||
| HAD |
Base, n = 100 |
1 mo, n = 95 |
2 mo, n = 86 |
3 mo, n = 81 |
6 mo, n = 75 |
12 mo, n = 71 |
|
|
||||||
| Anxiety* |
5.4 (4.5–6.3) |
4.1 (3.2–5.0) |
3.1 (2.4–3.8) |
4.5 (2.8–4.3) |
3.4 (2.5–4.4) |
3.2 (2.2–4.1) |
| p†/ES‡ |
0.00/0.31 |
0.00/0.50 |
0.00/0.37 |
0.00/0.41 |
0.00/0.51 |
|
| Depression* |
3.7 (3.0–4.5) |
4.0 (3.2–4.8) |
3.2 (2.6–3.8) |
2.9 (2.3–3.5) |
2.8 (2.0–3.6) |
2.5 (1.7–3.3) |
| p†/ES‡ |
ns/0.12 |
ns/0.03 |
ns/0.08 |
ns/0.07 |
ns/0.20 |
|
|
*Min-max score 0–21 †p-value significant at ≤ 0.05, ns = not significant ‡Effect size (ES) of change was calculated as mean change from baseline, divided by the standard deviation of change. Criteria: trivial 0 to < 0.20; small 0.20 to < 0.50; moderate 0.50 to < 0.80; and large ≥ 0.80 | ||||||
Johansson et al. BMC Cancer 2008 8:80 doi:10.1186/1471-2407-8-80 |
||||||